Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.

Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM.

Nat Commun. 2015 Feb 20;6:6341. doi: 10.1038/ncomms7341.

2.

Release of dengue virus genome induced by a peptide inhibitor.

Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF.

PLoS One. 2012;7(11):e50995. doi: 10.1371/journal.pone.0050995. Epub 2012 Nov 30.

3.

The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.

Zhang Q, Hunke C, Yau YH, Seow V, Lee S, Tanner LB, Guan XL, Wenk MR, Fibriansah G, Chew PL, Kukkaro P, Biukovic G, Shi PY, Shochat SG, Grüber G, Lok SM.

J Biol Chem. 2012 Nov 23;287(48):40525-34. doi: 10.1074/jbc.M112.384446. Epub 2012 Oct 3.

4.

Resistance analysis of an antibody that selectively inhibits dengue virus serotype-1.

Zou G, Kukkaro P, Lok SM, Ng JK, Tan GK, Hanson BJ, Alonso S, MacAry PA, Shi PY.

Antiviral Res. 2012 Sep;95(3):216-23. doi: 10.1016/j.antiviral.2012.06.010. Epub 2012 Jul 4.

PMID:
22771779
5.

The structural basis for serotype-specific neutralization of dengue virus by a human antibody.

Teoh EP, Kukkaro P, Teo EW, Lim AP, Tan TT, Yip A, Schul W, Aung M, Kostyuchenko VA, Leo YS, Chan SH, Smith KG, Chan AH, Zou G, Ooi EE, Kemeny DM, Tan GK, Ng JK, Ng ML, Alonso S, Fisher D, Shi PY, Hanson BJ, Lok SM, MacAry PA.

Sci Transl Med. 2012 Jun 20;4(139):139ra83. doi: 10.1126/scitranslmed.3003888.

6.

2'-O methylation of internal adenosine by flavivirus NS5 methyltransferase.

Dong H, Chang DC, Hua MH, Lim SP, Chionh YH, Hia F, Lee YH, Kukkaro P, Lok SM, Dedon PC, Shi PY.

PLoS Pathog. 2012;8(4):e1002642. doi: 10.1371/journal.ppat.1002642. Epub 2012 Apr 5.

7.

New, closely related haloarchaeal viral elements with different nucleic Acid types.

Roine E, Kukkaro P, Paulin L, Laurinavicius S, Domanska A, Somerharju P, Bamford DH.

J Virol. 2010 Apr;84(7):3682-9. doi: 10.1128/JVI.01879-09. Epub 2010 Jan 20.

8.

Virus-host interactions in environments with a wide range of ionic strengths.

Kukkaro P, Bamford DH.

Environ Microbiol Rep. 2009 Feb;1(1):71-7. doi: 10.1111/j.1758-2229.2008.00007.x.

PMID:
23765723
9.

Quantitative dissociation of archaeal virus SH1 reveals distinct capsid proteins and a lipid core.

Kivelä HM, Roine E, Kukkaro P, Laurinavicius S, Somerharju P, Bamford DH.

Virology. 2006 Dec 5-20;356(1-2):4-11. Epub 2006 Aug 28.

10.

Constituents of SH1, a novel lipid-containing virus infecting the halophilic euryarchaeon Haloarcula hispanica.

Bamford DH, Ravantti JJ, Rönnholm G, Laurinavicius S, Kukkaro P, Dyall-Smith M, Somerharju P, Kalkkinen N, Bamford JK.

J Virol. 2005 Jul;79(14):9097-107.

11.

SH1: A novel, spherical halovirus isolated from an Australian hypersaline lake.

Porter K, Kukkaro P, Bamford JK, Bath C, Kivelä HM, Dyall-Smith ML, Bamford DH.

Virology. 2005 Apr 25;335(1):22-33.

Supplemental Content

Loading ...
Support Center